Annual accounts
Total Exemption Full accounts
30/09/2026Filing deadline
Made up to 31/12/2024Due 30/09/2026
- Next accounts made up to
- 31/12/2025
- Last accounts made up to
- 31/12/2024
IMPERAGEN LIMITED
Active- 13761050Copy
Copy
Registry details
Reference data exactly as held at Companies House.
Copy registry details
- Registered office
- Unit 11, Williams House Lloyd Street North, Manchester Science Park, Manchester M15 6SE
- Classification (SIC)
- Research and experimental development on biotechnology (72.11 - SIC 2007)
- Accounts type
- Total Exemption Full
Company activity
The 4 most recent documents filed at Companies House.
Pre-Score for UK companies is coming soon
- 12/05/2026View PDF (9 pages)
Total exemption full accounts made up to 2025-12-31
- 20/04/2026View PDF (4 pages)
Statement of capital following an allotment of shares on 2026-04-13
- 20/04/2026View PDF (4 pages)
Statement of capital following an allotment of shares on 2026-04-17
- 17/04/2026View PDF (5 pages)
Replacement Filing of Confirmation Statement dated 9999-12-31
Coming soon
What Pre-Score will tell you
- Whether the filed accounts are strengthening or weakening year on year.
- Whether this company files on time, and how often its record changes.
- How its officers and controlling parties connect to other UK companies.
Accounts and confirmation statement
The two filings Companies House requires every year, and where each one stands against its deadline today.
Due in 5 days
Confirmation statement
Confirms the registry record is up to date
- Next statement date
- 06/12/2026
- Last statement dated
- 31/12/2024
Financial performance
The latest figures IMPERAGEN LIMITED filed. Okredo holds filed accounts data for 2022–2025; the year-by-year record is on the financials page.
Net Assets
£1.55M2025
2.08%vs 20242024: £1.52M
Total Assets
£2.09M2025
-11.43%vs 20242024: £2.36M
Cash in Bank
£975.41K2025
62.96%vs 20242024: £598.56K
Total Liabilities
£59.33K2025
-33.34%vs 20242024: £89.01K
Employees
142025
+2vs 20242024: 12
Of the 4 measures with an earlier filing to compare against, 2 rose and 2 fell. Cash in bank moved furthest, up 62.96% on 2024. See the full financial analysis for IMPERAGEN LIMITED.
The full financial record
Four ways through IMPERAGEN LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Net Assets · -20.5% a year (CAGR)Three-year trend, 2023–2025Every measure end to end across 2023, 2024 and 2025, with the compound rate behind each one.See what moved5 chartsCharts by indicator5 filed indicators plotted year by year, 2022–2025.Plot the figuresNothing estimatedRatios from the filed figures4 ratios computed from this company's own reported amounts, each shown against the year it was derived from.Check the ratios5 × 4 yearsEvery figure by yearAll 5 measures Okredo tracks across 4 reported years, exactly as filed.Open the table
Employees
Headcount as reported to Companies House for 2022–2025.
| Year | Employees | Change |
|---|---|---|
| 2025 | 14 | +2 |
| 2024 | 12 | +3 |
| 2023 | 9 | +6 |
| 2022 | 3 | – |
Reported employee count increased from 3 in 2022 to 14 in 2025. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
- Company potential
- Risk indicators
- Past performance
- Future prospects
Officers
12Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 28/07/2022–06/09/2023 | 27 | |
| Corporate Director | 28/07/2022–Present | 61 | |
| Director | 06/09/2023–03/10/2024 | 15 | |
| Director | 23/11/2021–17/09/2025 | 1 | |
| Director | 23/11/2021–Present | 1 | |
| Director | 23/11/2021–17/09/2025 | 1 | |
| Director | 23/11/2021–13/06/2022 | 0 | |
| Director | 05/01/2026–Present | 1 | |
| Director | 23/10/2024–20/11/2025 | 13 | |
| Director | 23/10/2024–Present | 1 | |
| Director | 20/11/2025–Present | 1 | |
| Director | 04/07/2023–Present | 0 |
Persons with significant control
1Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 23/11/2021–Present | 0 |
Filing history and recent activity
Every document on the Companies House record, newest first.
- Filings on record
- 33 Since 11/08/2022
- Last 12 months
- 12 +1 vs the year before
- Most recent filing
- 12/05/2026 4 months ago
What changed in the last year
- Accounts filedLatest 12/05/2026
- Share capital (3)Latest 20/04/2026
- Confirmation statement (2)Latest 17/04/2026
- Officer changes (6)Latest 27/01/2026
Filing timeline
- 12/05/2026View PDF (9 pages)
Total exemption full accounts made up to 2025-12-31
- 20/04/2026View PDF (4 pages)
Statement of capital following an allotment of shares on 2026-04-13
- 20/04/2026View PDF (4 pages)
Statement of capital following an allotment of shares on 2026-04-17
- 17/04/2026View PDF (5 pages)
Replacement Filing of Confirmation Statement dated 9999-12-31
- 27/01/2026View PDF (2 pages)
Appointment of Mr Guy Levy-Yurista as a director on 2026-01-05
- 19/12/2025View PDF (5 pages)
Confirmation statement made on 2025-12-06 with updates
- 25/11/2025View PDF (2 pages)
Appointment of Mr James William Gibbons as a director on 2025-11-20
- 24/11/2025View PDF (1 pages)
Termination of appointment of Jessica Mccreadie as a director on 2025-11-20
- 07/10/2025View PDF (0 pages)
Second filing for the termination of Timothy John Eyes as a director
- 07/10/2025View PDF (4 pages)
Second filing for the termination of Andrew Almond as a director
- 07/10/2025View PDF (4 pages)
Second filing for the termination of Timothy John Eyes as a director
- 01/10/2025View PDF (4 pages)
Replacement filing of SH01 - 17/09/25 Statement of Capital gbp 17.0097
Showing 12 of 33 filings
See when the next accounts and confirmation statement are due
Similar companies
40 UK companies are similar to IMPERAGEN LIMITED, sharing the same company status (Active), the same industry sector and activity group (Research and experimental development on biotechnology) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
LINICAL UK LIMITED
ActiveMeacher-Jones, 6 St John's Court, Vicars Lane, Chester, Cheshire CH1 1QE
- Activity
- Research and experimental development on biotechnology
- Company no.
- 09318613
- Incorporated
- 19/11/2014
- Employees
- 13
BIOCORTEX LTD
Active167-169 Great Portland Street, London W1W 5PF
- Activity
- Research and experimental development on biotechnology
- Company no.
- 13287534
- Incorporated
- 23/03/2021
- Employees
- 13
LABOUR RESEARCH DEPARTMENT
Active3 St George's Mews, Westminster Bridge Road, London SE1 7JB
- Activity
- Research and experimental development on social sciences and humanities
- Company no.
- 11429402
- Incorporated
- 22/06/2018
- Employees
- 11
ALGAECYTES LIMITED
ActiveCamburgh House, 27 New Dover Road, Canterbury, Kent CT1 3DN
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 07264317
- Incorporated
- 25/05/2010
- Employees
- 13
APPLIED AGI LIMITED
Active1 Friar Street, Reading RG1 1DA
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 12211733
- Incorporated
- 17/09/2019
- Employees
- 14
About IMPERAGEN LIMITED
A short description of the company, written from its Companies House record.
IMPERAGEN LIMITED is a private limited company registered in the United Kingdom, based in Unit 11, Williams House Lloyd Street North, Manchester Science Park, Manchester M15 6SE. Companies House classifies its business as Research and experimental development on biotechnology. It has been on the register for 4 years 10 months.
The register currently records it as active. Its 2025 accounts report net assets of £1.55M and 14 employees.
IMPERAGEN LIMITED: frequently asked questions
Answered from this company's own registry record and filed figures.
What does IMPERAGEN LIMITED do?
Companies House records IMPERAGEN LIMITED under one registered business activity: Research and experimental development on biotechnology (72.11 - SIC 2007).
Is IMPERAGEN LIMITED still active?
IMPERAGEN LIMITED is recorded as active on the Companies House register, and has been on it since 23/11/2021.
What are IMPERAGEN LIMITED's latest reported financials?
The most recent accounts Okredo holds cover 2025 and report net assets of £1.55M, total assets of £2.09M, cash in bank of £975.41K and total liabilities of £59.33K.
When did IMPERAGEN LIMITED last file with Companies House?
The most recent document on the record is dated 12/05/2026: Total exemption full accounts made up to 2025-12-31, 4 months ago.
When are IMPERAGEN LIMITED's next filings due?
On the current registry record, accounts are due by 30/09/2026.
Who runs IMPERAGEN LIMITED?
Companies House lists 12 officers (6 currently in post) and 1 person with significant control.